Axonics’ sacral neuromodulation device cleared in Australia
Axonics says that its device significantly reduces the user's need to recharge as it marks its second clearance in only a ...
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Axonics, Inc. (Nasdaq: AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics R20® rechargeable sacral neuromodulation ...
MassDevice13 小时
Axonics wins regulatory nod in Australia for latest sacral neuromod system
Axonics announced today that it received regulatory approval in Australia for its R20 rechargeable sacral neuromodulation ...
Flow Space on MSN13 小时
Is Frequent Urination Normal? Dr. Kelly Casperson's Answer May Surprise You
Despite being an essential part of overall well-being, many women don't realize how much their urinary and pelvic health can ...
CNET on MSN11 小时
Peeing Too Much at Night? 5 Things to Start Doing to Save Your Sleep
If you have to get out of bed to run to the bathroom at night, you know how badly it can mess up your sleep. Thankfully, ...
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna ...
Urology of Virginia creates summit to answer health questions
Sometimes asking questions about your health and aging can be uncomfortable, or even embarrassing, but it doesn’t have to be ...
Public Radio Tulsa7 小时
The FDA approves a new type of schizophrenia drug
The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.